Matrine inhibits the PI3K/AKT pathway in tumor cells, while the reverse occurs in normal cells (Niu et al., 2014; Xie et al., 2015; Liu S. Q. et al., 2017; Wu X. et al., 2017; Chen et al., 2019; Zhang et al., 2019). Here, AKT1 is linked to neoplasm.